Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation (SPADE)
Sponsor: Ottawa Hospital Research Institute
Terminated
Recommendation from the DSMB following recurrent DVT in 3/4 participants who underwent the thrombectomy procedure.
Other terminated trials from Ottawa Hospital Research Institute
- Stroke Sequelae · Phase NA · Apr 2022
- Focus: Smoking Cessation as it Relates to Fracture Healing · Phase NA · Jul 2021
- Proximal Humerus Fracture · Phase NA · Jan 2021
- Lymph Node Disease · Phase NA · Jun 2020
- Antiphospholipid Syndrome in Pregnancy · Phase EARLY_PHASE1 · Oct 2019
See all terminations from Ottawa Hospital Research Institute
Other Deep Vein Thrombosis trials with similar outcome
Listed as NCT02066597, this PHASE2 trial focuses on Deep Vein Thrombosis and Venous Thromboembolism and remains terminated or withdrawn. Sponsored by Ottawa Hospital Research Institute, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE2
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ottawa Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .